Press release
Complete PDF Guide On Pharmacogenomics [PDF]
Pharmacogenomics Market
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10808
Key Players Analysis:
Hoffmann-la Roche Ltd
Abbott
Oxford Nanopore Technologies
Thermo Fisher Scientific Inc.
Illumina, Inc.
QIAGEN
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Admera Health
Dynamic DNA Laboratories
The report covers key developments in the
Pharmacogenomics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pharmacogenomics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pharmacogenomics Market in the global market. Below mentioned is the list of few companies engaged in the Pharmacogenomics Market.
Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behaviour & the growth of the market as well as industries.
MARKET SEGMENTATION
Based on classification system, the market is segmented as Healthcare Common Procedure Coding System (HCPCS) and International Classification of Diseases (ICD). Based on component, the market is segmented as outsourced and in-house. Based on end user, the market is segmented as hospitals, diagnostic centers, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pharmacogenomics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2030 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pharmacogenomics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Pharmacogenomics, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Complete PDF Guide On Pharmacogenomics [PDF] here
News-ID: 3352223 • Views: …
More Releases from The Insight Partners
Global Foam Plastics Market Set to Expand Through 2031
The Foam Plastics Market is experiencing robust momentum worldwide as industries from construction to automotive seek lightweight, high-performance, and energy-efficient materials. Foam plastics - versatile polymer-based materials known for superior insulation, cushioning, and structural properties - are emerging as key enablers of innovation across end-use sectors.
Recent industry analysis highlights a strong growth trajectory for the foam plastics market through 2031, fueled by expanding industrial demand, rising sustainability imperatives, and continuous…
Global Food Firming Agents Market Forecasts Robust Growth Through 2031
The Food Firming Agents Market is poised for sustained expansion over the coming years as food manufacturers respond to evolving consumer preferences for quality, texture, and longer shelf life in processed foods. Driven by the shifting landscape of food innovation, increasing demand for natural solutions, and rapid industrial growth in key regions, market players are strategically positioning themselves to deliver enhanced performance and compliance with global food safety standards.
Firming agents…
Herbicides Market Set to Transform Global Agriculture by 2031
The Herbicides Market is undergoing a dynamic transformation, driven by the growing need for sustainable farming practices, efficient weed management, and higher crop yields. Herbicides-whether selective or non-selective-play a crucial role in modern agriculture, ensuring that crops thrive without competition from invasive weeds. As the world faces increasing food demand, herbicides are becoming indispensable tools for farmers across cereals, grains, oilseeds, pulses, fruits, and vegetables.
PDF Copy @: https://www.theinsightpartners.com/sample/TIPRE00007594/?utm_source=OpenPR&utm_medium=10188
Herbicides : Competitive…
Managed Detection and Response (MDR) Market Sees Surge Amid Escalating Cyber Thr …
Managed Detection and Response (MDR) services deliver round-the-clock threat monitoring and rapid response, helping organizations combat sophisticated cyber risks without building massive in-house teams. Drawing from recent industry analysis, this press release highlights key market dynamics as of early 2026. It focuses on drivers, trends, and opportunities shaping the space.
The Managed Detection and Response (MDR) Market is expected to register a CAGR of 24% from 2025 to 2031.
Download PDF Sample…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.'
Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366
According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period…
